Trypanosomiasis Global Clinical Trials Review, H1, 2012 (Related Reports)

Trypanosomiasis Global Clinical Trials Review, H1, 2012


February 29, 2012
85 Pages - SKU: GBDT3806304
License type:
Online Download      US $1,000.00
Global Site License      US $3,000.00
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014 provides data on the B-Cell Non-Hodgkin Lymphoma clinical trial scenario. This report provides elemental  |  read more...
$2,500.00
Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014 provides data on the Low-Grade Astrocytoma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Low-Grade Glioma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Low-Grade Glioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Low-Grade Glioma Global Clinical Trials Review, H1, 2014 provides data on the Low-Grade Glioma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014 provides data on the Lymphoblastic Lymphoma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Malignant Ascites Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Malignant Ascites Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Malignant Ascites Global Clinical Trials Review, H1, 2014 provides data on the Malignant Ascites clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Malignant Glioma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Malignant Glioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Malignant Glioma Global Clinical Trials Review, H1, 2014 provides data on the Malignant Glioma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014 provides data on the Metastatic Breast Cancer clinical trial scenario. This report provides elemental  |  read more...
$2,500.00
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 provides data on the Non-Small Cell Lung Cancer clinical trial scenario. This  |  read more...
$2,500.00
Pontine Glioma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Pontine Glioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Pontine Glioma Global Clinical Trials Review, H1, 2014 provides data on the Pontine Glioma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant
4/14/2014 | published by: GBI Research
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma  |  read more...
$3,500.00